ANEXO I FICHA TÉCNICA O RESUMEN DE LAS …
Abilify Maintena 300 mg polvo y disolvente para suspensión de liberación prolongada inyectable en jeringa precargada
Download ANEXO I FICHA TÉCNICA O RESUMEN DE LAS …
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Product, Management, Lifecycle, Product lifecycle management
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guidelines, Good, Practices, Clinical, Good clinical practice e6
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
Guidelines, European, Agency, Medicine, Harmonised, European medicines agency, Ich harmonised
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Product, Medicinal, Traditional, Herbal, Products1 traditional herbal medicinal products, Products1
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Good, Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Good manufacturing practice for active, Good manufacturing practice for active pharmaceutical ingredients
Related documents
PROGRAMA DE EQUIVALENTES TERAPÉUTICOS
www.elcomprimido.comPrograma de Equivalentes Terrapéuticos. PET. Hospital Universitario Son Dureta. 3ª edición. Junio 2001 3 PROGRAMA DE EQUIVALENTES TERAPÉUTICOS
Cuestionario de nombre del paciente …
www.immunize.orgCuestionario de . contraindicaciones para la vacuna inyectable contra la gripe. nombre del paciente . fecha de nacimiento
DECLARACION DE INFORMACIÓN DE VACUNA …
www.immunize.org¿En qué me debo fijar? • Fíjese en cualquier cosa que le preocupe, como los síntomas de una reacción alérgica grave, fiebre muy alta o comportamientos inusuales.
GLUCONATO DE CALCIO LAVOISIER 10%, solución …
www.lavoisier.comGLUCONATO DE CALCIO LAVOISIER 10%, Solución inyectable FTPF/A/(ES)/22/UV/D/05.08 GLUCONATO DE CALCIO LAVOISIER 10%, solución inyectable
COMISION NACIONAL DE PRECIOS DE …
www.med-informatica.comREPUBLICA DE COLOMBIA It COMISION NACIONAL DE PRECIOS DE MEDICAMENTOS Y DISPOSITIVOS MEDICOS CIRCULAR No. 04 DE 2012 Por la cual se incorporan unos medicamentos al régimen de control directo
FOLLETO DE INFORMACIÓN AL PACIENTE PROLIA …
www.tecnofarma.clFOLLETO DE INFORMACIÓN AL PACIENTE PROLIA SOLUCIÓN INYECTABLE 60mg/mL PROLIA Solución inyectable 60 mg/mL Lea cuidadosamente este folleto antes de la administración de este